These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF. Reddy N; Everhart A; Eling T; Glasgow W Biochem Biophys Res Commun; 1997 Feb; 231(1):111-6. PubMed ID: 9070230 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship for potentiation of EGF-dependent mitogenesis by oxygenated metabolites of linoleic acid. Glasgow WC; Eling TE Arch Biochem Biophys; 1994 Jun; 311(2):286-92. PubMed ID: 8203891 [TBL] [Abstract][Full Text] [Related]
7. Modulation of c-jun and jun-B messenger RNA and inhibition of DNA synthesis by prostaglandin E2 in Syrian hamster embryo cells. Cowlen MS; Eling TE Cancer Res; 1992 Dec; 52(24):6912-6. PubMed ID: 1333886 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin synthase 2 expression in epidermal growth factor-dependent proliferation of mouse keratinocytes. Loftin CD; Eling TE Arch Biochem Biophys; 1996 Jun; 330(2):419-29. PubMed ID: 8660674 [TBL] [Abstract][Full Text] [Related]
9. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression. Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805 [TBL] [Abstract][Full Text] [Related]
10. Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis. Eling TE; Glasgow WC Cancer Metastasis Rev; 1994 Dec; 13(3-4):397-410. PubMed ID: 7712598 [TBL] [Abstract][Full Text] [Related]
11. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin. Wang Z; Wang M; Carr BI J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927 [TBL] [Abstract][Full Text] [Related]
14. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Shah BH; Olivares-Reyes JA; Catt KJ Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor. Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852 [TBL] [Abstract][Full Text] [Related]
16. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA. Li J; Ma C; Huang Y; Luo J; Huang C Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890 [TBL] [Abstract][Full Text] [Related]